I think I've pissed myself

Not the full ticket

The Belmont bawds and her fellow Medtext molls have taken to changing the From header to bypass sender block rules, but retain the Reply-To address, so that they can receive direct replies. Cunning, no?

Vanessa Williams, bless her, hasn't quite cottoned on. I found this in my junk mail folder, because she used a previous From address. But, she did change the Reply-To address. (rolleyes)

From: Annals of Clinical Pharmacology & Toxicology(ISSN: 2642-9233)
 <editor@ijoapmedtext.com>
Reply-To: Annals of Clinical Pharmacology & Toxicology(ISSN: 2642-9233)
 <vanessawilliams@medtextopenj.info>
[snip] We are also accepting articles from your colleagues, friends and students. Looking forward to hearing from you soon. Best Regards, Vanessa Williams MedtextPublications 6355 N Clairmont Avenue Chicago 60659 United States

Is that the truth, or a lie, Vanny? Have any of my colleagues really submitted articles to your esteemed journal of irrelevance?

<img width="1" height="1" src="http://192.53.161.180/mail/index.php/campaigns/ds7370dh872cc/track-opening/[snip]" alt="" />

Update

26.03.2022 21:45

Unsurprisingly, Vanessa's next message, on behalf of The Gynecologist, ended up in my junk mail folder, for the wee lamb had used the same mailer address for a different journal.

Clearly, the game is to choose one mailer address for each campaign run, and all the molls use that for their various journals. But I have no idea whose pen name she's using. (confused)

Subject: Support our Journal by Submitting Valuable Contribution - 
 The Gynecologist (ISSN: 2688-9366)
From: The Gynecologist (ISSN: 2688-9366) <editor@ijoapmedtext.com>
Reply-To: The Gynecologist (ISSN: 2688-9366)
 <vanessawilliams@medtextopenj.info>
Greetings from Pen Name..! We are very lucky to contact an eminent researcher like you…!! “The Gynecologist (ISSN: 2688-9366)”, welcomes you to submit an article for the Upcoming Issue in “Gynecology” about to be released in the month of April 2022. We kindly request you to share your manuscript like Research, Review, Case Reports/Case Series/Clinical Cases/Case Study/Short Communication (2-4 pages)/Editorial (2 pages)/Clinical Images (150 words)/Letter to the Editor/Opinion on any topic and which falls in the journal scope, so that we can process and publish it for the Upcoming Issue of our journal. Kindly submit the article on or before 30th April 2022. The due date can be extended as per your convenience. Kindly attach your manuscript directly to this email or submit through the following Submission E-mail: submissions@medtextpublications.com Thank you for your time and consideration in this matter. I hope you can help in this matter. We are looking forward to receiving your reply. Best Regards, Vanessa Williams MedtextPublications 6355 N Clairmont Avenue Chicago 60659 United States
<img width="1" height="1" src="http://192.53.161.180/mail/index.php/campaigns/tq842arh0t386/track-opening/[snip]" alt="" />

Update

22.06.2022 10:33

This one contains most of the hallmarks of solid, predatory spam: changed From header; urgency, we tried several times…; unwarranted praise; irrelevant scope; extendable deadline; submission by email, rather than a trackable upload platform; substandard English; tracking image; deceptive adress details. But it adds a little something special: recognition that I have priorities and committments.

In respect of this, Vanessa doesn't want to overburden me, by requesting a full manuscript. She's such an understanding soul. All she wants is at least one of a number of shorter-form submissions. I have no idea what a case blog entails, but then I'm not a clinician. This blog, detailing cases of unsolicited solicitations, probably doesn't count though.

I wonder if an opinion piece or letter to the editor addressing the prevalence of spam from garbage-tier web comics would be acceptable?

Date: Wed, 22 Jun 2022 05:40:01 +0000
Subject:Editorial or Short Communication Submission Request for Upcoming
 Issue - Annals of Clinical Pharmacology & Toxicology(ISSN: 2642-9233)
From: Annals of Clinical Pharmacology & Toxicology(ISSN: 2642-9233)
 <editor@journal.mpmedtext.com>
Reply-To: Annals of Clinical Pharmacology & Toxicology(ISSN: 2642-9233)
 <vanessawilliams@medtextopenj.info>
Salutations from Vanessa..! I hope you would be fine and trust this e-mail finds you well. We tried several times, but there is no response from you, we would like to contact you again!! The Editorial Team of “Annals of Clinical Pharmacology & Toxicology(ISSN: 2642-9233)” Journal is pleased to invite eminent authors like you to submit your valuable contributions to our scholarly journal. We understand your priorities and professional commitments. It would not be appropriate at this point in time to overburden you by asking you to write/contribute a full-length manuscript. So, we kindly request you to submit at least Mini-review/Editorial/Short Communication/ Case Blog/Clinical Videos/Commentaries/Opinion/150 words Clinical Image/Letter to the Editor to our journal. Kindly attach your manuscript directly to this email or submit through the following Submission E-mail: submissions@medtextpublications.com Timeline for submission is 15th July; 2022 and can be extendable if needed. We would be grateful if you consider the proposal and submit your manuscript to the issue and make it successful. Looking forward to hearing from you soon. Best Regards, Vanessa Williams Medtextpublications 6355 N Clairmont Avenue Chicago 60659 United States Unsubscribe
<img width="1" height="1" src="http://104.237.135.172/mail/index.php/campaigns/sd581ps94q44b/track-opening/[snip]" alt="" />